XML 27 R12.htm IDEA: XBRL DOCUMENT
v3.22.4

INTANGIBLE ASSETS | 12 Months Ended
--- | ---
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
INTANGIBLE ASSETS | INTANGIBLE ASSETS Intangible Assets, Net consisted of the following:
| December 31,
| 2022 |  | 2021
Finite-lived intangible assets | $ | 690,871 |  |  | $ | 677,350 |
Accumulated amortization | (352,302) |  |  | (288,698) |
Net carrying value | $ | 338,569 |  |  | $ | 388,652 |
The following table summarizes the carrying value and estimated remaining life of the Company’s finite-lived intangible assets as of December 31, 2022:
| Net Balance |  | Average Remaining Life
Acquired intellectual property | $ | 240,321 |  |  | 5.1 years
Technology transfer | 86,578 |  |  | 5.4 years (1)
Repurchased royalty rights | 6,188 |  |  | 0.9 years
License payments | 5,436 |  |  | 7.7 years
Other | 46 |  |  | 0.3 years
Total | $ | 338,569 |  |  |
(1)Certain technology transfer intangible assets have not yet been placed into service. The average remaining life presented is only for those placed into service. As of December 31, 2022, the estimated future amortization expense associated with the Company’s finite-lived intangible assets that have been placed into service, was as follows:
Fiscal Year |  | Amount
2023 |  | $ | 63,688 |
2024 |  | 57,413 |
2025 |  | 38,136 |
2026 |  | 38,136 |
2027 |  | 38,136 |
Thereafter |  | 25,746 |
|  | $ | 261,255 |
In 2022 the Company completed the sale of a Rare Pediatric Disease Priority Review Voucher (PRV) the Company received from the Food and Drug Administration (FDA) in connection with the U.S. approval of VOXZOGO. As a result of the PRV sale, the Company recognized a $108.0 million net gain on sale of nonfinancial assets in the first quarter of 2022 on the Company's Consolidated Statement of Operations.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI https://asc.fasb.org/subtopic&trid=2144471 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration